IP Verse

Cellvax competitive analysis

Loading summary...

Latest patents of Cellvax opposed by its competitors

Explore Cellvax's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3152234
Jun 26, 2024Antibody Which Is Directed Against Galectin-9 And Is An Inhibitor Of The Suppressor Activity Of Regulatory T Lymphocytes1

Latest publications and patents of Cellvax New

Explore the latest publications and patents granted to Cellvax, showcasing their recent innovations and technological advancements.

Last updated on: Oct 20, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Cellvax

EP3152234
Jun 26, 2024Antibody Which Is Directed Against Galectin-9 And Is An Inhibitor Of The Suppressor Activity Of Regulatory T LymphocytesPatent Maintained As Amended

Latest PTAB cases involving Cellvax

Discover the latest PTAB cases involving Cellvax, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Cellvax with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CELLVAX - 1 - -
HOFFMANN EITLE148 - - -